In recent years, the visibility of Taiwanese brands in the international medical field has continued to rise. As a professional oxygen machine R&D and manufacturing company, Faciox Inc. will participate in Medical Fair Thailand 2025 (MFT) from September 10 to 12, 2025. The company will be at booth T03, showcasing its latest generation of portable oxygen concentrator, the POC101. We sincerely invite partners from all sectors to visit for exchange and collaboration.

Official Exhibition Website: Medical Fair Thailand

MFT (Medical Fair Thailand): An Important Gateway to the ASEAN Medical Industry

MFT (Medical Fair Thailand) is currently the largest and most influential medical exhibition in Southeast Asia, attracting over a thousand medical equipment and health tech companies from around the globe. It covers diverse fields such as medical devices, smart healthcare, long-term care, and respiratory therapy. For companies hoping to expand into the ASEAN market, it's an unmissable platform for networking and collaboration.

Faciox Inc. has been deeply committed to the Asian market for many years. This participation is not only a significant step in the brand's internationalization but also an excellent opportunity to bring "Made-in-Taiwan" and "smart healthcare" to the global stage.

New Product Debut: POC101 Portable Oxygen Concentrator

At this exhibition, Faciox Inc. will make a grand launch of its latest product—the POC101 portable oxygen concentrator.

Product Features:

• Lightweight Design: Specifically engineered for home use, travel, and long-term care needs. Its small and light build makes it easy to carry on the go.

• Stable Oxygen Supply: A high-efficiency molecular sieve combined with a smart control system ensures a stable oxygen supply over long periods.

• Low-Noise Operation: Provides a quiet and comfortable user experience, suitable for long-term use.

• Multi-Country Certifications: Passed ISO 13485 certification, meeting the demands of international markets.

The debut of the POC101 will meet the needs of the long-term care market, respiratory therapy patients, and multinational medical institutions, making it a benchmark for the next generation of portable oxygen machines.